Outcomes and Adverse Events of WHO Shorter Regimen in the Treatment of Multi‐Drug Resistant Tuberculosis in Bhutan: A Longitudinal Study
The treatment success rate of MDR-TB was high, with high sputum and culture conversion rates. Adequate monitoring of side effects is important in providing timely intervention.
Authors
- Tandin Zangpo (ORCID: https://orcid.org/0000-0002-3863-2666)
- Gaki Nima (ORCID: https://orcid.org/0000-0002-2434-7151)
- Thinley Dorji (ORCID: https://orcid.org/0000-0003-4932-8704)
- Chencho Dorji
Institutions
- Sir Charles Gairdner Hospital (AU)
- Centre for Bhutan Studies and GNH Research (BT)
- Khesar Gyalpo University of Medical Sciences of Bhutan (BT)
- Royal University of Bhutan (BT)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/hsr2.71241
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40